Twenty three single nucleotide polymorphisms (SNPs) among nine genes associated with type 2 diabetes or obesity were investigated. Samples were obtained from 737 NTD case-parent triads included in the National Birth Defects Prevention Study (NBDPS). Log-linear models were used to evaluate maternal and offspring genetic effects. Both spina bifida and anencephaly were investigated.
Main findings from this research  Maternal genetic effects on NTD risk were observed among three obesity and diabetes related genes (FTO, TCF7L2 and LEP) . FTO encodes a protein that is associated with body fat accumulation. Variants in TCF7L2 are known markers for type 2 diabetes; LEP encodes the hormone leptin that has a profound effect on eating behavior and metabolic rate.
 An offspring genetic effect on NTD risk was observed in the gene encoding uncoupling protein 2, which is involved in energy metabolism.
Conclusion and discussion
In one of the largest studies of its kind, our findings suggest that maternal genes involved in glucose metabolism and obesity may modify a woman's risk of having a NTD-affected pregnancy. To our knowledge, this is the first report to identify the role of maternal obesity/diabetes genes in the development of NTDs. This is important as maternal genes influence the baby's environment during pregnancy. These findings must be replicated, but eventually may help in identifying those women at the greatest risk of have a NTD-affects pregnancy. 
